Skip to main content Skip to main navigation menu Skip to site footer
Page Header Logo
  • Home
  • About
    • About the Journal
    • Aims & scope
    • Editorial Board
    • Contact Information
  • Current
  • Archives
  • Indexing & Abstracting
  • For Authors
    • Author Guidelines
    • Peer Review Policy
    • Ethical Consideration
    • Publication Ethics and Malpractice Statement
    • Submissions
Search
  • Register
  • Login
  1. Home /
  2. Search

Advanced filters
Correction: GDP versus ESHAP Regimen in Relapsed and/or Refractory Hodgkin lymphoma: A Comparison Study
Mani Ramzi, Aliraza Rezvani, Mehdi Dehghani
Published: 2015-10-01
Short View of Leukemia Diagnosis and Treatment in Iran
Mehdi Azad, Ramin Bakhshi Biniaz, Mehdi Goudarzi, Naser Mobarra, Shaban Alizadeh, Hajar Nasiri, Ali Dehghani Fard, Saeid Kaviani, Mohamad Hossein Moghadasi, Mohammad Reza Sarookhani, Mousa Vatanmakan, Mehdi Sahmani
ESHAP versus IEV Chemotherapy for Relapsed or Refractory Hodgkin's and Non- Hodgkin's Lymphoma
Mehdi Dehghani, Reza Vojdani, Abolfazl Khalafi-Nezhad, Mohammad Reza Ravanbod, Mani Ramzi, Shima Dehdashti, Erfan Taheri Fard, Nasrin Namdari
Published: 2025-04-20
GDP versus ESHAP Regimen in Relapsed and/or Refractory Hodgkin lymphoma: A Comparison Study
Mani Ramzi, Aliraza Rezvani, Mehdi Dehghani
1 - 4 of 4 items


2023 CiteScore: 1.3

pISSN: 2008-3009
eISSN: 2008-2207

Editor-in-Chief:
Ardeshir Ghavamzadeh, MD.

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).

1.3
2023CiteScore
 
 
36th percentile
Powered by  Scopus

 

SCImago Journal & Country Rank

Make a Submission
Information
  • Publication Fee
  • For Readers
  • For Authors
  • For Librarians
International Journal of Hematology-Oncology and Stem Cell Research (Quarterly), pISSN: 2008-3009, eISSN: 2008-2207
Tehran University of Medical Sciences, Tehran, Iran.

All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source.